New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. (57/84)

 (+info)

Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker. (58/84)

 (+info)

Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and mice. (59/84)

 (+info)

Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus. (60/84)

 (+info)

Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50). (61/84)

 (+info)

Structure of alanine racemase from Oenococcus oeni with bound pyridoxal 5'-phosphate. (62/84)

 (+info)

Heavy-enzyme kinetic isotope effects on proton transfer in alanine racemase. (63/84)

 (+info)

Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones. (64/84)

 (+info)